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Abstract
Background:  The development of biosensors, based on surface plasmon resonance (SPR)
technology, enables monitoring of a variety of biospecific interactions without the need for
chemical-, biological- or radiological-labelled reagents.
Method: We utilised SPR to detect hepatocyte growth factor (HGF) in reconstituted faecal
samples and studied samples from patients with infectious gastroenteritis (n = 20) and normal
controls (n = 10). Mouse anti-human HGF monoclonal antibodies and recombinant human HGF
receptor (c-Met)/Fc chimera were immobilised in flow cells of a CM5 biosensor chip.
Results: We found that infectious gastroenteritis produced a higher signal response compared to
controls, due to binding of HGF to monoclonal anti-HGF antibody as well as binding of HGF to c-
Met receptor (p < 0.01). The SPR signal response correlated with results from ELISA (r = 72%, p
> 0.001). The signal response decreased significantly (p < 0.05) when samples were diluted with
dextran, because of reduction in both specific as well as unspecific binding of HGF to dextran. The
decrease in the specific response might imply that the dextran- binding site for HGF overlaps with
the antibody binding epitope, or that dextran binding induces a conformational change of the HGF
molecule. Bands corresponding to HGF were found by gel electrophoresis of purified faeces in an
affinity chromatography column immobilised by HGF ligands.
Conclusion: Determination of HGF by SPR might be beneficial in diagnosis of acute situations that
present with symptoms of gastroenteritis and may, possibly, guide appropriate medical treatments.
This is to our knowledge the first report on the use of SPR for detection of HGF in faeces samples.
Background
The SPR technique is suitable for studying biomolecular
interactions on, or close to, a surface [1]. SPR enables
rapid detection in real time without any labeling of sam-
ples and can be utilised for concentration determination,
kinetics studies and epitope mapping. In brief, light
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incident on a metal surface at a given angle of incidence
can excite a surface-bound electromagnetic wave, a surface
plasmon, which propagates along the interface between
the metal and the ambient medium. Associated with the
surface plasmon is an evanescent field that probes local
changes in the refractive index of the ambient medium,
induced, for example, by binding of a biomolecule to the
surface. The change in refractive index will shift the angle
of incidence at which the SPR excitation occurs. This shift
in the angle is tracked by monitoring the movement of
intensity minima of the reflected light with time using the
Kretschmann configuration, and the binding event is pre-
sented as a sensorgram [1]. The sensor surface of the SPR
apparatus consists of a carboxy-methylated dextran
matrix, which is a hydrogel providing a solution-like envi-
ronment in which the biospecific interactions occur. The
carboxyl groups in the dextran matrix enable covalent
coupling of ligands (proteins, receptors, DNA etc) to the
surface.
Hepatocyte growth factor (HGF) is a growth factor that is
produced by mesenchymal cells during injuries in various
organs. It stimulates cell division [2], motility [3], and a
normal morphogenic structure [4] in the epithelial cells
that have survived an injury (adjacent to the injured area).
HGF is translated as a single-chain precursor and activated
at the site of injury by proteolytic cleavage, resulting in a
double-chained active HGF [5]. Interaction between the
active HGF and its specific receptor (c-Met) [6] initiates
intracellular signal pathways that result in regeneration
and repair of damaged tissue [7]. High amounts of HGF
have been determined systemically during injuries caused
by infection [8]. At the site of infection, a local production
of HGF has been found during bacterial meningitis and
pneumonia [9,10].
Using a commercially available ELISA kit, we have shown
that the concentration of HGF in faeces increases signifi-
cantly during infectious gastroenteritis [11]. The levels
decrease to normal after recovery. We have further studied
the presence and stability of HGF in faeces samples during
infectious processes [12]. Since traditional immunoassays
(e.g., ELISA) are time-consuming and laborious, there is a
need for quicker and simpler methods. In this study we
present a method based on surface plasmon resonance,
SPR, which allow us to detect and measure the levels of
HGF in faeces in individual samples with the same accu-
racy but more rapidly than traditional methods.
Methods
Patients
Nine patients admitted to hospital with signs of acute
untreated infectious diarrhoea were included. These
patients had participated in a previous study [11]. Faeces
samples were taken at admittance and cultured (Campylo-
bacter, Salmonella and Shigella), and laboratory diagnostic
tests for Rotavirus (antigen detection) and Calicivirus (elec-
tron microscopy) as well as cultures and cytotoxin analy-
sis for Clostridium difficile were conducted. Cultures and
cytotoxin analysis (toxin A) were positive for Clostridium
difficile in 1 case. Cultures revealed growth of Campylo-
bacter jejuni in 4 cases. Salmonella art (Salmonella DO) was
found in 3 cases. Faeces culture was negative in one
patient. This patient had diarrhoea and fever and his wife
had gastroenteritis caused by Campylobacter jejuni. A sec-
ond group of eleven patients with Clostridium difficile
(positive culture and toxin A) were also analysed. This
gave a total of 20 samples of faeces from 20 patients (11
women, 9 men, range 20–85, median 51.5 and mean 52
year). Faeces haemoglobin (Actim Fecal Blood test; Orion
Diagnostica) was examined and was positive in 10/13
samples.
Controls
Faeces samples were obtained from 10 healthy vaccina-
tion volunteers (six women and four men, 20–60 years)
without signs of infection or diarrhoea. Faeces culture and
diagnostic tests for Rotavirus and Caliciviruswere negative
in all of these cases. These patients had negative Actim
Fecal Blood test results (Orion Diagnostica)
Standardizing faeces volume and reconstitution procedure
All faeces samples were stored at -20°C. Prior to handling,
the samples were thawed at room temperature and mixed
using a Vortex (Vortex-Genie, Scientific Industries Inc.,
Bohemia, NY, USA). The samples were then placed at -
70°C for 15 minutes, followed by room temperature for 2
minutes and dissolved in distilled water at a dilution of
1:6. The suspension was centrifuged at 1000–3000 G for
15 minutes and the supernatant stored at -70°C until
analysed.
To avoid the effects of digestive as well as bacterial
enzymes, protease inhibitor (1–5%) (Sigma Aldrich) with
specific inhibition of serine, cysteine, aspartic proteases
and aminopeptidases, containing 4-(2-aminoethyl) ben-
zenesulfonyl fluoride (AEBSF), pepstatinA, E-64, bestatin,
leupeptin, and aprotinin (but no metal chelators) was
added to the thawed samples (room temperature) 30
minutes prior to analysis.
SPR measurements and ligand immobilisation procedures
SPR measurements were conducted at 760 nm in a fully
automatic Biacore 2000 instrument and a semi-automatic
Bicaore X instrument (Biacore AB, Uppsala, Sweden)
equipped with four and two flow cells respectively. The
flow cell temperature was 25°C in all experiments. The
sample surfaces used were carboxy-methylated dextran
CM5 chips (Biacore AB, Uppsala, Sweden). Coupling of
ligands to the carboxylic acid groups of the dextranBMC Gastroenterology 2005, 5:13 http://www.biomedcentral.com/1471-230X/5/13
Page 3 of 8
(page number not for citation purposes)
hydrogel was carried out by conventional carbodiimide
chemistry using 200 mM EDC (N-ethyl-N' -(3-diethylami-
nopropyl) carbodiimide) and 50 mM NHS (N-hydroxy-
succinimide). The activation time was 7 min, followed by
a 2–7 min ligand injection. Deactivation of remaining
active esters was performed by a 7 min injection of eth-
anolamine/hydrochloride at pH 8.5. A flow rate of 5 µl/
min was used during immobilisation. All ligands were
diluted in 10 mM acetate buffer pH 4.5, i.e., below the
protein isoelectric point, thus enhancing the electrostatic
interactions between the dextran matrix and the ligands.
The monoclonal anti-HGF (500 µg/ml) was diluted 1:10,
the recombinant Met proto-oncogene receptor (100 µg/
ml) 1:5, and the HGF recombinant (5 ug/ml) 1:3. The
contact time varied between two and seven minutes
resulting in levels of immobilisation between 8000 and
30000 RU (response units). After deactivation, the sur-
faces were washed with five subsequent one-minute injec-
tions of 5 mM glycine buffer pH 2.0 with 1 M NaCl. One
of the flow cells was used as a reference to monitor the
response due to buffer and unspecific interactions. This
flow cell was treated in the same way as the other during
the immobilisation procedure, but omitting the ligand
immobilisation step.
Determination of faeces HGF by ELISA
After storage all samples were thawed and centrifuged at
1000 G for 15 minutes prior to analysis. Immunoreactive
HGF was determined by ELISA using a commercially
available kit (Quantikine HGF Immunoassay, R&D Sys-
tems Inc., Minneapolis, USA).
Determination of faeces haemoglobin
Actim Fecal Blood (Orion Diagnostica) is an immuno-
chromography technique that is specific for the determi-
nation of human haemoglobin using two monoclonal
antibodies. The detection limit in faeces is 50 µg haemo-
globin/L or 25–50 µg haemoglobin/g. The method detects
the intact haemoglobin molecule, but neither haemo-
globin that is influenced by the enzymes during gastroin-
testinal passage nor animal haemoglobin is detected.
Purification of faecal samples by affinity chromatography, 
ultrafiltration, and SDS-PAGE
The affinity chromatography columns (Hi-trap Amer-
sham Biosciences) were immobilised with monoclonal
anti-human HGF and recombinant human HGF receptor
(c-MET)/Fc chimera (R&D Systems) respectively. Faeces
samples were reconstituted in distilled water. The samples
were applied to the 500 µl centrifugal tubes (Amicon
Ultra, Millipore, S.A.S. Molsheim, France) and centrifuged
at 4000 G for one hour. SDS-PAGE was performed with
the faeces samples before and after purification and filtra-
tion, using a 4% stacking gel and a 12% running acryla-
mide gel [13]. For size estimation prestained protein
standard (Sigma Aldrich) was electrophoresed
simultaneously.
Statistics
Non-parametric Friedman and Wilcoxon signed rank tests
(absolute values, Statview & SPSS Base 11.0) were used.
The Spearman rank correlation coefficient was used for
analysis of correlation between parameters. A p-value ≤
0.05 was regarded as statistically significant.
Results
Patients with infectious gastroenteritis had significantly
higher signal responses in flow cells immobilised with
monoclonal anti-HGF antibody compared to the healthy
controls (determined in at least six independent experi-
ments)(Friedman p = 0.006, Wilcoxen Signed Rank Tests
p = 0.008) (Fig 1 and 2). The signal responses in the flow
cells immobilised with c-Met receptor were also signifi-
cantly higher in the group with infectious gastroenteritis
(Wilcoxen Signed Rank Tests, p = 0.02).
Correlation with ELISA
Determination of HGF in faeces (patients with infectious
gastroenteritis) by utilising SPR correlated significantly (n
= 20, r = 72%, p < 0.001) with the levels measured by
ELISA (range 0.14–8.24, median 0.83 ng/mL) (Fig 3).
HGF levels determined by ELISA in healthy controls (n =
10) were low (range 0.01–0.26, median 0.06)
Correlation with age
We found a negative correlation between the SPR signal
intensity and age in patients with infectious gastroenteritis
(n = 20, r = - 0.55, p = 0.010) (Fig 4). The patients with
Histogram showing signal responses determined by SPR  (channel immobilised by mouse anti-human HGF monoclonal  antibodies) in infectious gastroenteritis (n = 20, median 1895  ± 429 RU, range 123–6660 RU) and healthy controls (n = 10,  median 171 ± 38 RU, range 14–459 RU) Figure 1
Histogram showing signal responses determined by SPR 
(channel immobilised by mouse anti-human HGF monoclonal 
antibodies) in infectious gastroenteritis (n = 20, median 1895 
± 429 RU, range 123–6660 RU) and healthy controls (n = 10, 
median 171 ± 38 RU, range 14–459 RU). The response is 
defined as the difference in response signal before and after 
the injection of the sample minus the difference observed in 
the reference channel.BMC Gastroenterology 2005, 5:13 http://www.biomedcentral.com/1471-230X/5/13
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acute gastroenteritis were older than the healthy controls
(median 51.5 respective 35.0 years).
Effects of altering the immobilisation levels
The effect on signal responses due to the amount of mon-
oclonal anti-HGF antibody immobilised was determined
in different samples (n = 12). Increasing the immobilisa-
tion levels by increasing the contact time during immobi-
lisation (1, 5, and 10 minutes) caused a significantly
higher response of all samples (Friedman p < 0.01, Wil-
coxon signed ranks test between 1 and 5 minutes p =
0.058, between 5 and 10 minutes p = 0.003, and between
1 and 10 minutes p = 0.003) (Fig 5). Altering the flow rate
(5, 10, and 15 µl/min) did not have a significant effect on
the response of the different samples (Friedman p = 0.48)
(data not shown). When altering levels of immobilisation
of the c-Met receptor (n = 15), no effect in responses in the
case of infection (P = 0.85) was observed. Changing of the
flow rate (5, 10, and 15 µl/min) did not influence the sig-
nal responses (P = 0.36) (data not shown).
Binding of HGF to dextran
Addition of dextran (0.05%) to the samples resulted in a
significant (p < 0.05) decrease in signal responses in flow
cells with immobilised anti-HGF but did not affect the
HGF binding to c-met (p = 0.11). Diluting recombinant
HGF with dextran (0.05%) also resulted in a decrease of
binding to the monoclonal anti-HGF antibody (n = 3).
The test of significance was not performed.
SDS-PAGE
We investigated the presence of HGF in the samples by
SDS-PAGE of faeces samples as well as SDS-PAGE of puri-
fied faeces samples in an affinity chromatography column
SPR sensogram showing the signal obtained from analysis of faeces from a patient with infectious gastroenteritis Figure 2
SPR sensogram showing the signal obtained from analysis of faeces from a patient with infectious gastroenteritis. Note the dif-
ference in signal intensity between the control channel (dextran) and the channel immobilised by mouse anti-human HGF mon-
oclonal antibody.BMC Gastroenterology 2005, 5:13 http://www.biomedcentral.com/1471-230X/5/13
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immobilised by either mouse anti-human HGF mono-
clonal antibody or recombinant human c-met receptor.
Bands corresponding to the HGF were detected with
apparent molecular masses of 75–90 kDa (Fig 6).
Protease Inhibitor
Faeces destroyed the proteins immobilised in the flow
cells of the CM5 chip (Fig 7). Adding protease inhibitor
(1–5%) to the faeces samples within 30 minutes prior to
experiments could inhibit this effect completely.
Discussion
In the present work the Surface Plasmon Resonance (SPR)
based method has been used for the first time to evaluate
faecal samples and monitor the relative amount of HGF in
the samples.
HGF has been investigated widely over the past decade.
The unique properties of this cytokine, makes it likely to
be involved in the recovery process after injuries [3].
Recent studies have strengthened the notion that HGF
plays an important role in the regeneration of an injured
organ [2]. Several researchers have attempted to treat
induced hazardous injuries in animal models by HGF
[14,15]. We have studied HGF during infectious diseases
and found that HGF was produced in high amounts both
systemically and locally during injuries caused by infec-
tion [8]. Low amounts of serum HGF in patients with
Correlation between the concentration of HGF in faeces  obtained by ELISA and signal responses by SPR (Spearman  rank correlation coefficient n = 20, r = 0.72, p < 0.001) Figure 3
Correlation between the concentration of HGF in faeces 
obtained by ELISA and signal responses by SPR (Spearman 
rank correlation coefficient n = 20, r = 0.72, p < 0.001). The 
shadow points along the regression line are not data points.
Correlation between age of the patients with infectious gas- troenteritis and signal responses by SPR (Spearman rank cor- relation coefficient r = - 0.55, p = 0.01) Figure 4
Correlation between age of the patients with infectious gas-
troenteritis and signal responses by SPR (Spearman rank cor-
relation coefficient r = - 0.55, p = 0.01). The shadow points 
along the regression line are not data points.
Histogram showing the effects of increasing the immobilisa- tion levels by increasing the contact time during immobilisa- tion (1–3 representing 1, 5, and 10 minutes) (Friedman p <  0.01, Wilcoxon signed ranks test between 1 and 5 minutes p  = 0.058, between 5 and 10 minutes p = 0.003, and between 1  and 10 minutes p = 0.003) Figure 5
Histogram showing the effects of increasing the immobilisa-
tion levels by increasing the contact time during immobilisa-
tion (1–3 representing 1, 5, and 10 minutes) (Friedman p < 
0.01, Wilcoxon signed ranks test between 1 and 5 minutes p 
= 0.058, between 5 and 10 minutes p = 0.003, and between 1 
and 10 minutes p = 0.003). The monoclonal anti-HGF (500 
µg/ml) was diluted 1:10 in 10 mM acetate buffer pH 4.5. The 
activation time was 7 min, followed by a 1,5 and 10 min ligand 
injection respectively. Deactivation of remaining active esters 
was performed by a 7 min injection of ethanolamine/hydro-
chloride at pH 8.5. A flow rate of 5 µl/min was used during 
immobilisation.BMC Gastroenterology 2005, 5:13 http://www.biomedcentral.com/1471-230X/5/13
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pneumonia correlated significantly to poor prognosis
[16]. Application of HGF locally at the site of an injury
such as a chronic ulcer resulted in an accelerated healing
process [17].
The gastrointestinal mucosa has a remarkable ability to
repair damage, and growth factors play an important role
in the regeneration of injured cells in gastrointestinal
organs [18]. Nishimura et al. (1998) [19] showed that
HGF was the most potent of the cytokines (HGF, TGF-α ,
TGF-β , and keratinocyte growth factor) in accelerating
repair of the damaged monolayer of an epithelial cell line
derived from normal rat small intestine. We studied the
amounts of HGF in faeces of patients with infectious gas-
troenteritis and found that the levels of HGF were signifi-
cantly elevated during infection [11]. Although this
observation might indicate healing of injury caused by an
infection, we could discriminate with high specificity and
sensitivity between infectious gastroenteritis and other
disorders that present with diarrhoea [11].
In a previous study [12] the concentration and stability of
HGF in fecal samples was investigated using ELISA.
Although the ELISA method was very reliable, it was labo-
rious and gave no information about the form of HGF
that was present in the samples. In the present study we
found that there is good correlation between the results
obtained from SPR and ELISA measurements of faecal
HGF levels. In some cases differences between results
obtained by ELISA and SPR are found and this phenome-
non is to be further investigated.
Using SPR we were able to monitor the presence of HGF
in the samples and the interactions between HGF and dif-
ferent ligands with different binding specificity to the
HGF molecule. First, a recombinant HGF that showed
affinity to the monoclonal anti-HGF antibody as well as c-
met receptor was examined (data not shown). The affinity
of recombinant HGF disappeared within one week after
reconstitution of the lyophilised form (data not shown).
On the other hand, the signal responses after analysis of
faeces samples in the patients with infectious
gastroenteritis were stable after reconstitution. We have
tested widely the stability of HGF in faeces samples by
ELISA [12] and previously in serum [20]. Unlike our pre-
vious observations [11] that showed no significant corre-
lation between age of patients and HGF levels determined
by ELISA, in this study we found a negative correlation
between age and SPR signal in the group with infectious
gastroenteritis. This might strengthen the notion that the
ability of HGF to interact with its ligand or possibly its
activity might change by age. Moreover, in spite of the fact
that patients with infectious gastroenteritis were older
than healthy controls they had higher SPR signals.
Presence of blood was shown in ten out of thirteen cases
with infectious gastroenteritis while it was negative in
healthy controls. However we have previously studied the
correlation between presence of blood in faeces and HGF
levels (determined by ELISA) and did not find any signif-
icant correlation [12].
The immoblised layer in the flow cells of the chip were
destroyed after analysis of faeces samples (Fig 7). Adding
protease inhibitor to the samples before analysis inhibited
this effect which might indicate the presence of proteases
in faeces. We have previously shown that adding protease
inhibitor to faeces does not influence the ability to detect
HGF by ELISA [12].
At least two binding sites for HGF on liver cell surfaces
have been demonstrated in rat: the heparin-resistant and
acid-washable site (HGF receptor, binding site) and the
heparin-washable site (low-affinity, cell-surface heparan
sulfate proteoglycan binding site) [21]. HGF has also been
reported to interact with the extracellular matrix [22]. The
low affinity sites may serve as a reservoir for the regulation
of endogenous HGF levels and provide a matrix for con-
version of promitogen to the two-chain form [21]. The
HGF detected during infectious gastroenteritis had bind-
ing affinity to dextran (proteoglycan). By adding carboxy-
SPS-PAGE of faeces Figure 6
SPS-PAGE of faeces. A: before purification; B: after purifica-
tion in an affinity chromatography column immobilised by 
mouse anti-human HGF monoclonal antibody; C: after purifi-
cation in an affinity chromatography column immobilised by 
recombinant human c-met/fc chimera.BMC Gastroenterology 2005, 5:13 http://www.biomedcentral.com/1471-230X/5/13
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methyl dextran (0.05%) to the samples, the levels of HGF
bound to the immobilised monoclonal anti-HGF
decreased significantly. Adding the same amount of dex-
tran to recombinant HGF gave the same result in signal
responses (data not shown). This might indicate a bind-
ing affinity of this form of HGF to dextran, which might
resemble such affinity to cell-surface heparan sulfate
proteoglycan binding sites. These binding sites either
overlap with the antibody-binding epitope or induce
conformation shift in the HGF upon binding to the dex-
tran, resulting in sterical hindrance and thus preventing
binding to the antibody.
Conclusion
Infectious gastroenteritis is a common disease in all soci-
eties. Determination of HGF by SPR is a reliable method
to evaluate the relative amounts of HGF in faeces. This
might be beneficial in diagnosis of acute situations that
present with symptoms of gastroenteritis and may, possi-
bly, guide appropriate medical treatments.
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